CorMedix (CRMD) Change in Receivables (2015 - 2025)
CorMedix (CRMD) posted Change in Receivables of $12.4 million for Q4 2025, down 85.8% sequentially from $87.3 million in Q3 2025, and down 63.97% YoY from $34.4 million in Q4 2024.
CorMedix (CRMD) Change in Receivables (2015 - 2025) Analysis & Trends
CorMedix has reported Change in Receivables for 10 years, with the latest figure at $12.4 million in Q4 2025.
- Quarterly Change in Receivables fell 63.97% year-over-year to $12.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $90.9 million (up 76.26% YoY) and the FY2025 annual result came in at $90.9 million, up 75.56% from the prior year.
- Change in Receivables declined to $12.4 million in Q4 2025 per CRMD's latest filing, from $87.3 million in the prior quarter.
- Over five years, Change in Receivables peaked at $87.3 million in Q3 2025 and troughed at -$11.7 million in Q2 2025.
- A 4-year average of $10.2 million and a median of $21337.0 in 2021 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 1825.73% in 2021, down 1290.7% in 2021.
- Over 4 years, Change in Receivables stood at $47354.0 in 2021, then slumped by 99.07% to $440.0 in 2022, then soared by 7818889.55% to $34.4 million in 2024, then plunged by 63.97% to $12.4 million in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered $12.4 million, $87.3 million, and -$11.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.40 Mn |
| Dec 31, 2025 | 12.40 Mn |
| Sep 30, 2025 | 87.27 Mn |
| Sep 30, 2025 | 87.27 Mn |
| Jun 30, 2025 | -11.71 Mn |
| Jun 30, 2025 | -11.71 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 34.40 Mn |
| Dec 31, 2024 | 34.40 Mn |
| Sep 30, 2024 | 17.18 Mn |
| Sep 30, 2024 | 17.18 Mn |
| Dec 31, 2022 | 440.00 |
| Dec 31, 2022 | 440.00 |
| Sep 30, 2022 | 1,155.00 |
| Sep 30, 2022 | 1,155.00 |
| Jun 30, 2022 | -1,864.00 |
| Jun 30, 2022 | -1,864.00 |
| Mar 31, 2022 | -41,874.00 |
| Mar 31, 2022 | -41,874.00 |